The effect of diminazene, an angiotensin‐converting enzyme 2 activator, on adenine‐induced chronic kidney disease in rats

MLA

Aly M. Abdelrahman, et al. “The Effect of Diminazene, an Angiotensin‐converting Enzyme 2 Activator, on Adenine‐induced Chronic Kidney Disease in Rats.” Fundamental & Clinical Pharmacology, vol. 37, Nov. 2022, pp. 235–44. EBSCOhost, https://doi.org/10.1111/fcp.12845.

APA

Aly M. Abdelrahman, Badreldin H. Ali, Haytham Ali, Priyadarsini Manoj, & Yousuf Al‐Suleimani. (2022). The effect of diminazene, an angiotensin‐converting enzyme 2 activator, on adenine‐induced chronic kidney disease in rats. Fundamental & Clinical Pharmacology, 37, 235–244. https://doi.org/10.1111/fcp.12845

Chicago

Aly M. Abdelrahman, Badreldin H. Ali, Haytham Ali, Priyadarsini Manoj, and Yousuf Al‐Suleimani. 2022. “The Effect of Diminazene, an Angiotensin‐converting Enzyme 2 Activator, on Adenine‐induced Chronic Kidney Disease in Rats.” Fundamental & Clinical Pharmacology 37 (November): 235–44. doi:10.1111/fcp.12845.